The Las Vegas Metropolitan Police Department and Harley-Davidson partnered to offer a free motorcycle safety training course as cooler weather approaches. This initiative comes as motorcycle fatalities are on the rise in Clark County, with 21 motorcycle riders among the 83 road deaths this year, many of whom were unlicensed. The course aims to educate riders on safety and reduce accidents, with organizers encouraging all riders, even experienced ones, to take training.

RTX Corporation (NYSE:RTX) is a major aerospace and defense company listed on the S&P 500, operating through its three principal units: Collins Aerospace, Pratt & Whitney, and Raytheon. The company's diverse business spans commercial aviation, military systems, and aerospace technology development, supported by a substantial backlog in both commercial and defense programs. RTX's operational structure includes significant manufacturing capacity, expansion into advanced technologies, and a focus on both original equipment and aftermarket services for commercial aircraft, positioning it as a key industrial enterprise within the S&P 500.

Piper Sandler initiated coverage on Nvidia (NVDA) with an Overweight rating and a $300 price target, suggesting a 34% upside. The firm views Nvidia as an AI compute leader, controlling 80% of the market by value, and estimates it trades at just 14 times fiscal 2028 earnings. However, this bullish outlook heavily depends on Nvidia achieving Piper's aggressive growth forecasts of a 47% CAGR for revenue and earnings through FY30E.

Boston Scientific (BSX) experienced a 2.3% drop in early trading following a cyberattack on August 25, 2026, which disrupted its manufacturing and shipping. The company now expects to miss its third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share, despite operations having resumed. This incident exposes operational vulnerabilities and adds near-term complications, though the demand for its products like Farapulse remains strong.

GE Healthcare Technologies (NASDAQ: GEHC) is reportedly in talks to acquire Sofie Biosciences for $1 billion to bolster its pharmaceutical diagnostics division, which manufactures chemicals for cancer scans. This potential acquisition would be GE Healthcare's second-largest since its spin-off from General Electric, as the company has struggled with its stock performance despite analyst bullishness and a significant investment from Nelson Peltz's Trian Fund Management.

WINTON GROUP Ltd acquired 236,400 shares of The Goodyear Tire & Rubber Company (NASDAQ:GT) worth approximately $1.56 million during the second quarter, bringing institutional ownership in the company to 84.19%. Goodyear recently reported a quarterly loss of $0.61 per share on $4.25 billion in revenue, with analysts maintaining a consensus "Hold" rating and an average price target of $8.26. The stock opened at $5.37, near its 52-week low.

Lululemon's stock has crashed by about 52% in 2026, reaching an eight-year low, but the company remains highly profitable and financially stable with a strong balance sheet. The article explores whether this downturn presents a buying opportunity or indicates a permanent decline in its brand advantage, particularly noting the impact of declining North American sales and increasing competition. Despite financial strength, the brand's long-term value hinges on its ability to reinvigorate product desirability and navigate unpredictable trade policies.

This article compares the rotisserie chickens from Costco and Sam's Club, both popular for their affordability and convenience. While Costco's Kirkland Signature chicken is praised for its consistent low price, Sam's Club's Member's Mark chicken often receives higher marks for flavor, moisture, and seasoning profile in taste tests. The choice between the two often comes down to individual culinary preferences.

Engineers Gate Manager LP acquired a new stake of 225,718 shares in The Gap, Inc. (NYSE:GAP) during the second quarter, valued at approximately $4.2 million, bringing their total ownership to 0.06%. This purchase comes as institutional investors collectively hold 58.81% of Gap's stock. Gap recently surpassed quarterly EPS expectations, reporting $0.52 against an estimated $0.48, despite a 2% year-over-year revenue decline.

Novartis has paid Monte Rosa Therapeutics a $50 million milestone payment after dosing the first patient in a Phase 2 trial for MRT-6160, a VAV1-targeted drug for Sjögren's disease. This is part of a larger deal potentially worth up to $2.1 billion. While Monte Rosa is advancing other pipeline candidates and has sufficient cash into 2029, the company faces growing losses and mixed investor sentiment regarding its future trajectory.